alkenes has been researched along with Breast Neoplasms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, J; Oh, JW; Oh, SR; Pham, TH; Ryu, HW; Yoon, DY; Yoon, JH | 1 |
| Abdellatif, KRA; Abo El-Ela, FI; Gamal F, A; Kharshoum, RM; Salem, HF | 1 |
| Bechmann, N; Kniess, T; Pietzsch, J | 1 |
| Abdellatif, KR; Belal, A; Omar, HA | 1 |
| Kodama, R; Nakahara, M; Nakamura, Y; Sanke, T; Tsujimoto, M; Yasuoka, H; Yoshidome, K | 1 |
| Bates, DJ; Gorczynski, MJ; King, SB; Lively, MO; Morrow, CS; Townsend, AJ | 1 |
| Chakravarti, B; Gupt, MP; Konwar, R; Sharma, A; Siddiqui, JA; Tripathi, RP | 1 |
| Abdellatif, KR; Chowdhury, MA; Huang, Z; Knaus, EE; Velázquez, CA | 1 |
| Beukes, DR; Blatch, GL; Chiwakata, MT; de la Mare, JA; Edkins, AL; Lawson, JC | 1 |
| Gust, R; Lubczyk, V | 2 |
| Ando, K; Chang, YC; Furukawa, C; Magae, J; Mizuta, N; Nakajima, H; Ozawa, S; Sakaguchi, K; Yamagishi, H | 1 |
| Kakudo, K; Nakahara, M; Nakamura, M; Nakamura, Y; Nakao, K; Tsujimoto, M; Yasuoka, H; Yoshidome, K | 1 |
| Albert, BJ; Czaicki, NL; Koide, K; Naka, T; Sivaramakrishnan, A | 1 |
| Knox, AJ; Lloyd, DG; Meegan, MJ; Smith, HM; Zisterer, DM | 1 |
| Chang, YC; Fujiwara, I; Furukawa, C; Magae, J; Mizuta, M; Mizuta, N; Nakajima, H; Sakaguchi, K | 1 |
| Barakat, RR | 1 |
| Boehm, T; Fleck, M; Hochmuth, A; Kaiser, WA; Malich, A; Reichenbach, JR | 1 |
| Ball, H; Schneider, MR; Schönenberger, H | 1 |
| Ward, HW | 1 |
| Cole, MP; Jones, CT; Todd, ID | 1 |
1 review(s) available for alkenes and Breast Neoplasms
| Article | Year |
|---|---|
Tamoxifen and the endometrium.
Topics: Alkenes; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Estrogens; Female; Genes, ras; Humans; Hyperplasia; Leiomyosarcoma; Mass Screening; Menopause; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Phenols; Polyps; Receptors, Estrogen; Risk; Tamoxifen | 1998 |
1 trial(s) available for alkenes and Breast Neoplasms
| Article | Year |
|---|---|
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.
Topics: Aged; Alkenes; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Ethylamines; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis | 1973 |
19 other study(ies) available for alkenes and Breast Neoplasms
| Article | Year |
|---|---|
Methyl Linderone Suppresses TPA-Stimulated IL-8 and MMP-9 Expression Via the ERK/STAT3 Pathway in MCF-7 Breast Cancer Cells.
Topics: Alkenes; Breast Neoplasms; Cell Movement; Cyclopentanes; Extracellular Signal-Regulated MAP Kinases; Humans; Interleukin-8; MAP Kinase Signaling System; Matrix Metalloproteinase 9; MCF-7 Cells; Phthalic Acids; STAT3 Transcription Factor | 2020 |
Treatment of breast cancer with engineered novel pH-sensitive triaryl-(Z)-olefin niosomes containing hydrogel: an
Topics: Alkenes; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Hydrogels; Hydrogen-Ion Concentration; Liposomes; Mice; Molecular Structure; Particle Size; Structure-Activity Relationship; Surface Properties; Tomography, X-Ray Computed; Viscosity | 2020 |
Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index.
Topics: Alkenes; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Human Umbilical Vein Endothelial Cells; Humans; Melanoma; Nitric Oxide Donors; Selective Estrogen Receptor Modulators; Therapeutic Index | 2019 |
Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues.
Topics: Alkenes; Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Models, Molecular; Tamoxifen | 2013 |
Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.
Topics: Adult; Aged; Aged, 80 and over; Alkenes; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prognosis; Receptors, CXCR4; Tyrosine | 2008 |
Noncatalytic interactions between glutathione S-transferases and nitroalkene fatty acids modulate nitroalkene-mediated activation of peroxisomal proliferator-activated receptor gamma.
Topics: Alkenes; Breast Neoplasms; Cell Line, Tumor; Fatty Acids; Female; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Nitro Compounds; PPAR gamma; Recombinant Proteins; Solubility; Spectrophotometry, Ultraviolet | 2009 |
Synthesis and anti breast cancer activity of biphenyl based chalcones.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Chalcones; Female; Humans | 2010 |
Triaryl (Z)-olefins suitable for radiolabeling with iodine-124 or fluorine-18 radionuclides for positron emission tomography imaging of estrogen positive breast tumors.
Topics: Alkenes; Breast Neoplasms; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Isotope Labeling; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2011 |
Quinones and halogenated monoterpenes of algal origin show anti-proliferative effects against breast cancer cells in vitro.
Topics: Alkenes; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; Monoterpenes; Plocamium; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sargassum | 2012 |
Investigations on the influence of terminal groups at the C2-propyl side chain of 1,1-bis(4-hydroxyphenyl)-2-phenylpent-1-ene and 1,1,2-tris(4-hydroxyphenyl)pent-1-ene on the estrogen receptor binding and the estrogenic/anti-estrogenic properties.
Topics: Alkenes; Binding, Competitive; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Humans; Inhibitory Concentration 50; Ligands; Luciferases; Plasmids; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Transfection; Tumor Cells, Cultured | 2003 |
Structure activity relationship studies on C2 side chain substituted 1,1-bis(4-methoxyphenyl)-2-phenylalkenes and 1,1,2-tris(4-methoxyphenyl)alkenes.
Topics: Alkenes; Animals; Antineoplastic Agents; Breast Neoplasms; Cattle; Cell Division; Cell Line, Tumor; Cytosol; Estradiol; Female; Humans; Hydroxylation; Luciferases; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Transcription, Genetic; Transfection; Uterus | 2003 |
Selective cytotoxicity of ascochlorin in ER-negative human breast cancer cell lines.
Topics: Alkenes; Apoptosis; Blotting, Western; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Nucleus; Cell Survival; Coloring Agents; Cytochromes c; DNA Damage; Dose-Response Relationship, Drug; Genes, Reporter; Humans; Luciferases; Phenols; Plasmids; Receptors, Estrogen; Tetrazolium Salts; Thiazoles | 2005 |
Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
Topics: Alkenes; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Survival Analysis; Tumor Suppressor Protein p53; Tyrosine; Vascular Endothelial Growth Factor C | 2006 |
Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue.
Topics: Alkadienes; Alkenes; Alkynes; Allyl Compounds; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Epoxy Compounds; Furans; Humans; Inhibitory Concentration 50; Models, Chemical; Oxidation-Reduction; Pyrans; Silver; Spiro Compounds; Stereoisomerism; Zirconium | 2007 |
Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.
Topics: Alkenes; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Ligands; Models, Molecular; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2007 |
Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity.
Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Longevity; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Phenols; Proto-Oncogene Proteins c-fos; Receptors, Estrogen; Survival Analysis; Tetrazolium Salts; Thiazoles; Transcription Factor AP-1; Xenograft Model Antitumor Assays | 2007 |
Contrast-enhanced near-infrared laser mammography with a prototype breast scanner: feasibility study with tissue phantoms and preliminary results of imaging experimental tumors.
Topics: Alkenes; Animals; Breast; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Humans; Indoles; Lasers; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Phantoms, Imaging | 2001 |
Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
Topics: Alkenes; Animals; Breast Neoplasms; Cell Line; Chemical Phenomena; Chemistry; Estrogen Antagonists; Female; Humans; Isomerism; Mammary Neoplasms, Experimental; Mice; Organ Size; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Terphenyl Compounds; Uterus | 1985 |
A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.
Topics: Adult; Aged; Alkenes; Anabolic Agents; Breast Neoplasms; Chronic Disease; Diethylstilbestrol; Estrogen Antagonists; Ethylamines; Female; Humans; Middle Aged; Recurrence | 1971 |